CIK 0001935979 · Large accelerated filer
Biohaven Ltd.
Sign in to watch- Ticker
- BHVN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Virgin Islands, British
- Entity type
- operating
- Phone
- 203-404-0410
- Business address
- 215 CHURCH STREET, NEW HAVEN, CT, 06510
- Former names
- Biohaven Research Ltd.
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure
- 4 Shares withheld for taxes SVP, Clinical Operations gave up 1,956 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,594 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 7,430 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 2,381 shares (to pay taxes)
- 4 Shares withheld for taxes VP, Chief Accounting Officer gave up 1,117 shares (to pay taxes)
- 8-K Event Other events
- 4 Open-market buy VP, Chief Accounting Officer bought 17,000 shares at $8.52 ($144,770)
- 4 Open-market buy Director bought 400,000 shares at $7.50 ($3,000,000)
- 4 Open-market buy Director bought 3,333,333 shares at $7.50 ($24,999,998)
- 4 Open-market buy Chief Executive Officer bought 666,666 shares at $7.50 ($4,999,995)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
Page 3 of 15 · 282 filings